Indraccolo, Stefano
Istituto Oncologico Veneto IOV - IRCCS,
Italy
2025 Rank: 157142
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4785 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 157142 | 155139 |
| Total Cites | 541 | 625 |
| H-index | 11 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 47 | 49 |
| Number of Single+First+Last Authored Papers | 89 | 89 |
| Total Cites to Single+First+Last Authored Papers | 156 | 174 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 504 | 558 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.12 |
| Self-Citation Percentage |
13.44%
|
|
Indraccolo, Stefano
Istituto Oncologico Veneto IOV - IRCCS,
Italy
2024 Rank: 130034
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4240 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 130034 | 134886 |
| Total Cites | 591 | 665 |
| H-index | 11 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 38 | 46 |
| Number of Single+First+Last Authored Papers | 85 | 85 |
| Total Cites to Single+First+Last Authored Papers | 177 | 200 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 537 | 585 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.14 |
| Self-Citation Percentage |
11.13%
|
|
Indraccolo, Stefano
Università degli Studi di Padova,
Italy
2023 Rank: 106722
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3805 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 106722 | 112163 |
| Total Cites | 635 | 712 |
| H-index | 12 | 13 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 53 | 58 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 191 | 199 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 577 | 634 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.12 |
| Self-Citation Percentage |
10.81%
|
|
Indraccolo, Stefano
Università degli Studi di Padova,
Italy
2022 Rank: 107108
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4022 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 107108 | 98914 |
| Total Cites | 626 | 732 |
| H-index | 13 | 15 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 6 | 7 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 54 | 61 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 178 | 197 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 564 | 634 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.15 |
| Self-Citation Percentage |
14.48%
|
|
Indraccolo, Stefano
Istituto Oncologico Veneto IOV - IRCCS,
Italy
2021 Rank: 126649
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4526 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 126649 | 121929 |
| Total Cites | 806 | 956 |
| H-index | 15 | 16 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 7 | 8 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 76 | 91 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 248 | 286 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 729 | 816 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.17 |
| Self-Citation Percentage |
15.69%
|
|
Indraccolo, Stefano
Istituto Oncologico Veneto IOV - IRCCS,
Italy
2020 Rank: 129574
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4497 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 129574 | 135272 |
| Total Cites | 498 | 582 |
| H-index | 11 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 45 | 49 |
| Number of Single+First+Last Authored Papers | 67 | 67 |
| Total Cites to Single+First+Last Authored Papers | 147 | 180 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 456 | 507 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.15 |
| Self-Citation Percentage |
14.43%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.